Evidence map›Paper›PMID 35891551›Full record

ArticleViruses2022

Off-Target Effect of Activation of NF-κB by HIV Latency Reversal Agents on Transposable Elements Expression.

Gislaine Curty, Luis P Iniguez, Marcelo A Soares, Douglas F Nixon, Miguel de Mulder Rougvie

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Gislaine CurtyOncovirology Program, Instituto Nacional de Cancer, Rio de Janeiro 20231-050, Brazil.ORCID 0000-0002-9501-9374
Luis P IniguezDivision of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.
Marcelo A SoaresOncovirology Program, Instituto Nacional de Cancer, Rio de Janeiro 20231-050, Brazil.ORCID 0000-0002-9013-2570
Douglas F NixonDivision of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0002-2801-1786
Miguel de Mulder RougvieDivision of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.ORCID 0000-0002-8026-7076
Cornell University · USInstituto Nacional de Câncer - INCA · BR

Funding

HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
Expression of CircRNAs in HIV infection and latencyR21AI152929 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DE MULDER ROUGVIE, MIGUEL · 2020 to 2021
$466k
NIAID NIH HHS AI152929NIH HHS UM1AI164559
6 · The paper itself

Abstract

Many drugs have been evaluated to reactivate HIV-1 from cellular reservoirs, but the off-target effects of these latency reversal agents (LRA) remain poorly defined. Transposable elements (TEs) are reactivated during HIV-1 infection, but studies of potential off-target drug effects on TE expression have been limited. We analyzed the differential expression of TEs induced by canonical and non-canonical NF-κB signaling. We evaluated the effect of PKC agonists (Bryostatin and Ingenol B) on the expression of TEs in memory CD4+ T cells. Ingenol B induced 38 differentially expressed TEs (17 HERV (45%) and 21 L1 (55%)). Interestingly, TE expression in effector memory CD4+ T cells was more affected by Bryostatin compared to other memory T-cell subsets, with 121 (107 upregulated and 14 downregulated) differentially expressed (DE) TEs. Of these, 31% (

Indexed as

DNA Transposable ElementsHIV InfectionsHIV SeropositivityNF-kappa BVirus LatencyBryostatinsCD4-Positive T-LymphocytesDiterpenesHIV-1HumansVirus ActivationBryostatinsDiterpenesDNA Transposable ElementsingenolNF-kappa BCD4+ T cellsHERVHIV-1human endogenous retroviruseslatency reversal agentsLINE-1PKC activationT-cell subsetstransposable elements

Identifiers

PMID35891551
PMCPMC9318874
OpenAlexW4286462599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.